Handelsbanken Helse Tema is an actively managed global healthcare fund with history going back to 2000. Its management company, Handelsbanken Fonder, is the fund company of Svenska Handelsbanken, based in Stockholm and wholly owned by the bank.
Investment philosophy
The fund is thematic. Investments are made primarily in companies linked to selected long-term themes where the managers expect a long period of growth. Examples of main themes are demographics, productivity, lifestyle and environment. The fund follows sustainability criteria that exclude certain sectors.
The managers
Christopher Sundman manages the fund from Stockholm and has done so since August 2022. He has worked at Handelsbanken since 2001 and has experience from the fund industry going back to 1987, including European equities at GotaTrygg and Alecta. He also manages Handelsbanken EMEA Tema. Caroline Banér has been co-manager since October 2024.
The portfolio
Despite the thematic mandate, the steady top holdings consist mainly of large, established pharmaceutical companies such as Eli Lilly, AstraZeneca and AbbVie. The US is the largest country.
FundTelligence description · 18/10/2026
Portfolio managers
CA
Portfolio Manager
On the fund since Oct 1, 2024
CH
Portfolio Manager
On the fund since Aug 1, 2022
Fund data is taken from the managers’ own reports, otherwise computed from NAV history and, as a last resort, taken from distributor listings. Not official figures; verify with the fund provider before investing.